The US Food and Drug Administration (FDA) approved Panzyga, manufactured by Octapharma AG, for the treatment of PI and ITP in 2018 and for CIDP in adults in 2021. Octapharma commercializes Panzyga ...

The severity of clinical manifestations in CAD can vary depending on the specific type of cold-sensitive antibodies involved. While cold agglutinin and Donath-Landsteiner antibodies recognize antigens ...

Dan Lier has light chain (AL) amyloidosis—the most common form of amyloidosis. Larry Luxner, senior correspondent for Rare Disease Advisor, interviews former college basketball player Dan Lier, a ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

The primary goals of AI personalization were to improve onboarding, boost medication initiation and adherence, and enhance physician follow-up. AllazoHealth’s artificial intelligence (AI)-powered ...

Overall, 80.9% of patients were in complete remission 1 year after diagnosis irrespective of GPA or MPA cases (79.7% vs 83.8%, respectively). The therapeutic armamentarium for individuals with ...

The overall pooled prevalence of cirrhosis in individuals with homozygous ZZ AATD was 8.17%. Individuals with homozygous ZZ alpha-1 antitrypsin deficiency (AATD) face a substantial burden of liver ...

New research indicates that obinutuzumab is a potentially effective and cost-effective treatment for patients with rituximab-resistant AAV. Obinutuzumab therapy demonstrated immunological superiority ...

91.7% of prognostic studies reported a significant association between bilirubin levels and outcomes. The levels of bilirubin and alkaline phosphatase, as well as composites including these 2, can be ...

Participants who developed certain malignancies such as Richter’s Syndrome and therapy-related myeloid cancers had the poorest prognosis. Individuals with chronic lymphocytic leukemia (CLL) or small ...

The prevalence of MS was greater in higher latitudes and to a lesser extent in countries with higher health care expenditures. The prevalence of multiple sclerosis (MS) is increasing globally, ...

This unique case underscores the importance of meticulous prenatal and postnatal immunologic workup when alloimmune conditions are suspected. A 37-year-old multiparous woman with RhD alloimmunization ...